Stock comparison
Natera, Inc. is 8.5x more valuable than VERACYTE, INC. by market capitalization ($40.37 B vs $4.73 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
NTRA is larger
Natera, Inc. is 8.5x more valuable than VERACYTE, INC. by market capitalization ($40.37 B vs $4.73 B).
Market value leader
NTRA
Natera, Inc. is 8.5x more valuable than VERACYTE, INC. by market capitalization ($40.37 B vs $4.73 B).
Revenue leader
NTRA
VCYT: $517.14M vs NTRA: $2.31B.
Profit leader
VCYT
VCYT: $66.40M vs NTRA: -$208.16M.
Margin leader
VCYT
VCYT: 12.8% vs NTRA: -9.0% net margin.
| Metric | VCYT | NTRA |
|---|---|---|
| Market cap | $4.73 B | $40.37 B |
| US-listed rank | #1462 | #386 |
| Revenue (latest FY) | $517.14M | $2.31B |
| Net income (latest FY) | $66.40M | -$208.16M |
| Net margin | 12.8% | -9.0% |
| P/E (trailing FY) | 71.3x | - |
| SEC filings | 1,124 | 1,695 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Natera, Inc. is 8.5x more valuable than VERACYTE, INC. by market capitalization ($40.37 B vs $4.73 B).
In their latest fiscal years, VERACYTE, INC. reported $517.14M in revenue while Natera, Inc. reported $2.31B.
Full pages: VERACYTE, INC. and Natera, Inc., or browse the full rankings.